Focal cortical dysplasia: comparison of MRI and FDG-PET

S K Kim1, D G Na, H S Byun

  • 1Department of Radiology, Samsung Medical Center, Sungkunkwan University School of Medicine, Seoul, Korea.

Abstract

Insights

[18F]fluorodeoxyglucose (FDG) positron emission tomography (PET) is more effective than MRI for diagnosing mild focal cortical dysplasia (FCD). FDG-PET better delineates cortical abnormalities, especially in less severe FCD cases.

Area of Science:

  • Neurology
  • Radiology
  • Medical Imaging

Background:

  • Focal cortical dysplasia (FCD) is a common cause of intractable epilepsy.
  • Accurate diagnosis and delineation of FCD are crucial for surgical planning and patient outcomes.
  • Magnetic resonance imaging (MRI) and [18F]fluorodeoxyglucose (FDG) positron emission tomography (PET) are key imaging modalities in FCD evaluation.

Purpose of the Study:

  • To compare the diagnostic utility of MRI and FDG-PET in identifying and characterizing focal cortical dysplasia (FCD).
  • To assess the sensitivity of each modality across different grades of FCD severity.

Main Methods:

  • Retrospective analysis of 19 patients with surgically confirmed FCD.
  • Comparison of MRI findings with histological FCD grading (Grades I, II, III).
  • Evaluation of FDG-PET findings in 17 of these patients, correlated with MRI and histology.

Main Results:

  • MRI detected lesions in 82% of Grade III FCD cases but only 13% of Grade I and II cases.
  • FDG-PET revealed cortical hypometabolism in 86% of Grade I/II FCD and 90% of Grade III FCD.
  • FDG-PET demonstrated a larger extent of cortical abnormality than MRI in 65% of evaluated patients.

Conclusions:

  • FDG-PET is superior to MRI in delineating cortical abnormalities, particularly in milder forms of FCD (Grade I and II).
  • FDG-PET provides a more comprehensive assessment of lesion extent compared to MRI.
  • Combined imaging may offer improved diagnostic accuracy for FCD.